- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Total 179 results
-
Qingdao Central HospitalCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... and other collaboratorsUnknownHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Istituto Scientifico Romagnolo per lo Studio e...CompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
Centro Nacional de Investigaciones Oncologicas...Fundacion CRIS de Investigación para Vencer el CáncerCompletedBreast Cancer | Early-Stage Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Rush University Medical CenterCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States
-
Montefiore Medical CenterAlbert Einstein College of Medicine; Deciphera Pharmaceuticals LLCTerminatedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast AdenocarcinomaUnited States
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
University of ArizonaNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
Gustave Roussy, Cancer Campus, Grand ParisEuropean CommissionCompletedUntreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast CancerFrance
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Tesaro, Inc.European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaboratorsTerminatedOvarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of BreastUnited States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
-
Reshma L. Mahtani, D.O.Gilead SciencesNot yet recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
SanofiUNC Lineberger Comprehensive Cancer CenterCompletedBrain Metastases | Estrogen Receptor Negative (ER-Negative) Breast Cancer | Progesterone Receptor Negative (PR-Negative) Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast CancerUnited States
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Carey Anders, M.D.Seagen Inc.RecruitingAdvanced Breast Cancer | Brain Metastases | Human Epidermal Growth Factor 2 Positive Carcinoma of BreastUnited States
-
AbbVieRecruitingHepatocellular Carcinoma | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Biliary Tract Cancers | Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer | Head and Neck Squamous-Cell CarcinomaUnited States, Israel, Japan
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitationHormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast CancerChina
-
NiKang Therapeutics, Inc.RecruitingSmall Cell Lung Carcinoma | Gastric Cancer | Ovarian Neoplasms | Ovarian Cancer | Solid Tumor | Endometrial Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Endometrial Cancer | Small-cell Lung Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Solid... and other conditionsUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Objective Response Rate | Overall Survival | Progression-free Survival | Epidermal Growth Factor Receptor | NimotuzumabChina
-
National University Hospital, SingaporeBoehringer IngelheimRecruitingNon-Small Cell Lung Cancer | Epidermal Growth Factor Receptor MutationSingapore
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
Ikena OncologyGilead SciencesTerminatedRenal Cell Carcinoma | Breast Cancer | Gynecologic Cancer | Colorectal Cancer | Ovarian Cancer | Lung Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Hormone Receptor/Growth Factor Receptor-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Guangdong Provincial People's HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor ReceptorChina
-
Indiana UniversityNational Cancer Institute (NCI); Indiana University Health; Eskenazi HealthActive, not recruitingBreast Cancer | Anxiety | Breast Neoplasm | Breast Carcinoma | Fear | Cancer of Breast | Malignant Tumor of Breast | Malignant Neoplasm of Breast | Mammary Cancer | Mammary Neoplasms, Human | Human Mammary Carcinoma | Mammary Carcinoma, HumanUnited States
-
Black Diamond Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | Metastatic Lung Cancer | Metastatic Lung Non-Small Cell Carcinoma | EGF-R Positive Non-Small Cell Lung Cancer | Advanced Lung Carcinoma | EGFR-TKI Resistant Mutation | Advanced Non-Small Cell Squamous Lung Cancer | Epidermal Growth Factor Receptor C797S | Epidermal...Korea, Republic of, United States
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
TJ Biopharma Co., Ltd.Active, not recruitingHead and Neck Squamous Cell Carcinoma | Triple-negative Breast CancerChina
-
Mayo ClinicNational Cancer Institute (NCI)CompletedHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Stage IV Breast Cancer | Invasive Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative...United States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States